EconoTimesHumanigen Signs Agreement With MD Anderson Cancer Center to Begin Research Investigating Lenzilumab as CAR …GlobeNewswire (press release)BRISBANE, Calif., April 16, 2018 (GLOBE NEWSWIRE) — Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical … Continue reading
Renal and Urology NewsChemo, Immunotherapy Feasible in Metastatic Bladder CancerRenal and Urology NewsA significantly higher response rate was seen in patients with deleterious somatic DNA damage response mutations. "Because chemotherapy and immun… Continue reading
Newsweek |
Breakthrough CRISPR Gene Editing Trial Set to Begin This Year
Newsweek Biotech company CRISPR Therapeutics is set to treat Europe’s patients with the CRISPR gene-editing tool this year following regulatory approval for trials. Researchers will apply the much-hyped tool to patients with beta thalassaemia, an inherited … Synthetic Molecules Could Improve CRISPRTechnology Networks Inventor, chemist, and CRISPR craftsman: Inside David Liu’s evolution workshopChemical & Engineering News |
|
Crispr sees gene therapy milestone in Europe
Seeking Alpha Crispr sees gene therapy milestone in Europe. Apr. 16, 2018 3:10 AM ET |By: Yoel Minkoff, SA News Editor. Humans are set to be genetically modified for the first time in Europe after regulators gave the go ahead to trial Crispr Therapeutics’ (NASDAQ … |